Quality’s Impact On COVID-19: Effective Vaccine Development
Published
In this third and final report in a series, long-time ASQ members and subject matter experts in the pharmaceutical industry offer their insights and reflections regarding the speed, safety, and success with which multiple vaccines were developed to fight COVID-19. Key findings in this case study include the ongoing relevance of Deming’s 14 points, the importance of focusing on patients over profits, and the powerful ways that a culture of quality impacted the outcome of vaccine development initiatives.
News
ASQ News
09/23/2021 3:33pm CDT
